The accumulation of MDSCs 22 together with CD4+CD25+ Treg cells 23–24 in both animal models and in cancer patients is a key feature of tumor progression contributing to immune suppression with strong inhibition and dysfunction of antitumor CD4+ T-helper cells (Th) and CD8+ cytolytic T lymphocytes (CTL). This evidence concerns the gene CD4 and cancer.